Filana Therapeutics, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Filana Therapeutics, Inc. now
Current reporting with the operating signal separated from the noise.
Filana Therapeutics, Inc.: Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
The story matters when it changes Filana Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Filana Therapeutics, Inc.: Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
The story matters when it changes Filana Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Filana Therapeutics, Inc. Common Stock
Investors are testing whether Filana Therapeutics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
The story matters when it changes Filana Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest FLNA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Filana Therapeutics, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →